Airbus SE said it has taken steps to shield itself from cyberattacks targeting the European aerospace and defense company through subcontractors’ computer systems.
The three major U.S. pharmacy chains are removing versions of the heartburn drug Zantac from store shelves as health regulators investigate a probable carcinogen detected in the popular stomach drugs.
A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.
Multiple reports are emerging from Xinjiang about human rights abuses against the indigenous Uyghur population, including mass detentions and the use of forced and child labor in local factories.
Manufacturers, retailers and distributors looking to make better use of working capital have a number of creative options at their disposal. But many prefer simply to slow-pay their suppliers.
Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills.
Saudi Arabia is racing to restore oil production after a brazen drone strike on a key Aramco facility slashed its output by half, removing about 5% of world supply.
The full scale of the damage a no-deal Brexit could cause to the U.K. was revealed when Boris Johnson’s government published its worst-case scenario — a document it tried to keep secret.
A draft executive order would target foreign shippers routing deliveries through the U.S. Postal Service — not the two-largest U.S. couriers United Parcel Service Inc. and FedEx Corp.
